Claus Escher

Long-term treatment of chronic migraine with OnabotulinumtoxinA: efficacy, quality of life and tolerability in a real-life setting

Katja Kollewe, Claus Escher, Dirk U. Wulff et al. · Journal of Neural Transmission · 2016 · 63 citations

Pharmacy, Pharmacology, Pharmacotherapy +8

Clinical Effect of Early vs Late Amyloid Positron Emission Tomography in Memory Clinic Patients

Daniele Altomare, Frederik Barkhof, Camilla Caprioglio et al. · JAMA Neurology · 2023 · 37 citations · Full text

Medicine, Neurology, Neuroscience +17

Analysis of Psychological Symptoms Following Disclosure of Amyloid–Positron Emission Tomography Imaging Results to Adults With Subjective Cognitive Decline

Camilla Caprioglio, Federica Ribaldi, Leonie N.C. Visser et al. · JAMA Network Open · 2023 · 34 citations · Full text

Medicine, Neuroscience, Psychiatry +17

Description of a European memory clinic cohort undergoing amyloid‐PET: The AMYPAD Diagnostic and Patient Management Study

Daniele Altomare, Lyduine E. Collij, Camilla Caprioglio et al. · Alzheimer s & Dementia · 2022 · 17 citations · Full text

Medicine, Neurology, Pharmacoeconomics +16

Botulinum neurotoxin serotype D – A potential treatment alternative for BoNT/A and B non-responding patients

Anna Kutschenko, Jasmin Weisemann, Katja Kollewe et al. · Clinical Neurophysiology · 2019 · 16 citations

Medicine, Neurology, Pharmacology +8